Evogene Ltd. (EVGN) vs MBody AI Ltd. (MBAI)

A side-by-side comparison of Evogene Ltd. and MBody AI Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

EVGN

Evogene Ltd.

$4M

$0.41HealthcareDelayed quote: Oct 6, 2026, 11:40 AM EDT

MBAI

MBody AI Ltd.

$3M

$3.20HealthcareDelayed quote: Oct 6, 2026, 11:42 AM EDT

Total return — EVGN vs MBAI

growth of $100 · dividends reinvested · last 1y

EVGN -67.2% (-67.2%/yr)MBAI -67.4% (-67.4%/yr)EVGN compounded faster over this window

EVGN MBAI

EVGN vs MBAI: by the numbers

•EVGN is the larger company ($4M vs $3M market cap).
•Both run net losses; MBAI's is the smaller (0.00% vs -694.19% net margin).

Metrics side by side

Valuation

Metric	EVGN	MBAI
P/S ratio	2.69	N/A
P/B ratio	N/A	0.93

Profitability

Metric	EVGN	MBAI
Gross margin	-6.25%	0.00%
Operating margin	-364.24%	0.00%
Net margin	-694.19%	0.00%
ROE	N/A	120.45%
ROIC	-130.12%	-69.04%

Growth (annualized)

Metric	EVGN	MBAI
Revenue CAGR (5Y)	2.86%	N/A
Total return CAGR (5Y)	-56.46%	N/A

Go deeper

Full EVGN analysis Full MBAI analysis Interactive comparison tool

Dig into the metrics

Evogene ROE MBody AI ROE Evogene operating margin MBody AI operating margin Evogene revenue growth MBody AI revenue growth Evogene free cash flow MBody AI free cash flow

Evogene & MBody AI appear in these rankings

Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.